141 related articles for article (PubMed ID: 6678857)
1. Mitoxantrone hydrochloride (NSC-310739) in lymphoma. A Southwest Oncology Group study.
Coltman CA; McDaniel TM; Balcerzak SP; Morrison FS; Von Hoff DD
Invest New Drugs; 1983; 1(1):65-70. PubMed ID: 6678857
[TBL] [Abstract][Full Text] [Related]
2. Methyl-glyoxal bis guanyl hydrazone (methyl-GAG, MGBG) in lymphoma and Hodgkin's disease. A Phase II trial of the Southwest Oncology Group.
Knight WA; Fabian C; Costanzi JJ; Jones SE; Coltman CA
Invest New Drugs; 1983; 1(3):235-7. PubMed ID: 6678871
[TBL] [Abstract][Full Text] [Related]
3. Mitoxantrone hydrochloride in lymphoma.
Coltman CA; McDaniel TM; Balcerzak SP; Morrison FS; Von Hoff DD
Cancer Treat Rev; 1983 Dec; 10 Suppl B():73-6. PubMed ID: 6661737
[No Abstract] [Full Text] [Related]
4. Phase II trial of 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino 9,10-anthracenedione dihydrochloride)(NSC 301739, DHAD) in patients with metastatic malignant melanoma. A Southwest Oncology Group pilot.
Taylor SA; Tranum BT; Von Hoff DD; Costanzi JJ
Invest New Drugs; 1985; 3(1):67-9. PubMed ID: 3988458
[TBL] [Abstract][Full Text] [Related]
5. Weekly mitoxantrone therapy of Hodgkin's disease, non-Hodgkin's lymphoma, and chronic lymphocytic leukemia. A Southeastern Cancer Study Group Trial.
Keller JW; Omura GA; Gams RA; Bartolucci AA
Am J Clin Oncol; 1987 Jun; 10(3):194-5. PubMed ID: 3591737
[TBL] [Abstract][Full Text] [Related]
6. [A phase II study of mitoxantrone in refractory and relapsed malignant lymphomas. Cooperative Study Group of Mitoxantrone in Malignant Lymphomas].
Kimura I; Ohnoshi T; Ogawa M; Sampi K; Masaoka T; Yamada K; Ohta K; Kitani T; Kawagoe H; Shirakawa S
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2800-6. PubMed ID: 3753026
[TBL] [Abstract][Full Text] [Related]
7. [A comparative study of mitoxantrone and adriamycin in patients with non-Hodgkin's lymphoma: a preliminary result].
Kimura I; Ohnoshi T; Masaoka T; Sampi K; Namba K
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2813-9. PubMed ID: 3530138
[TBL] [Abstract][Full Text] [Related]
8. Multicenter clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's disease.
Silver RT; Case DC; Wheeler RH; Miller TP; Stein RS; Stuart JJ; Peterson BA; Rivkin SE; Golomb HM; Costanzi
J Clin Oncol; 1991 May; 9(5):754-61. PubMed ID: 2016617
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of piperazinedione in Hodgkin's disease, non-Hodgkin's lymphoma, and multiple myeloma: a Southwest Oncology Group study.
Jones SE; Tucker WG; Haut A; Tranum BL; Vaughn C; Chase EM; Durie BG
Cancer Treat Rep; 1977 Dec; 61(9):1617-21. PubMed ID: 340032
[TBL] [Abstract][Full Text] [Related]
10. [A phase II study of mitoxantrone in malignant lymphoma].
Ibuka T; Sasaki T; Imai K; Sakai Y
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2612-7. PubMed ID: 3740861
[TBL] [Abstract][Full Text] [Related]
11. [Phase II study of mitoxantrone for hematologic malignancies].
Ueoka H; Ueno K; Yamane T; Toyoda K; Endo H; Nishihara R; Takahashi I; Ohnoshi T; Kitajima K; Kimura I
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2399-402. PubMed ID: 6639101
[TBL] [Abstract][Full Text] [Related]
12. Mitoxantrone in epithelial carcinoma of the ovary. A Southwest Oncology Group study.
Hilgers RD; Rivkin SE; Von Hoff DD; Alberts DS
Am J Clin Oncol; 1984 Oct; 7(5):499-501. PubMed ID: 6507370
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of dihydroxyanthracenedione (DHAD, mitoxantrone, NSC 301739) in advanced malignant melanoma.
Arseneau JC; Schoenfeld DA; Borden EC
Invest New Drugs; 1986; 4(1):53-6. PubMed ID: 3700041
[TBL] [Abstract][Full Text] [Related]
14. Gallium nitrate in malignant lymphoma: a Southwest Oncology Group study.
Weick JK; Stephens RL; Baker LH; Jones SE
Cancer Treat Rep; 1983 Sep; 67(9):823-5. PubMed ID: 6883359
[TBL] [Abstract][Full Text] [Related]
15. Mitoxantrone in malignant lymphoma.
Gams RA; Steinberg J; Posner L
Semin Oncol; 1984 Sep; 11(3 Suppl 1):47-9. PubMed ID: 6484580
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of mitoxantrone in multiple myeloma: a Southwest Oncology Group Study.
Alberts DS; Balcerzak SP; Bonnet JD; Stephens RL
Cancer Treat Rep; 1985 Nov; 69(11):1321-3. PubMed ID: 4092195
[TBL] [Abstract][Full Text] [Related]
17. Mitoxantrone in malignant lymphomas.
Gams RA; Keller JW; Golomb HM; Steinberg J; Dukart G
Cancer Treat Rev; 1983 Dec; 10 Suppl B():69-72. PubMed ID: 6661736
[No Abstract] [Full Text] [Related]
18. Mitoxantrone in malignant lymphoma.
Gams RA; Bryan S; Dukart G; Weiss A; Case D; Jones S; Stein R
Invest New Drugs; 1985; 3(2):219-22. PubMed ID: 4019123
[TBL] [Abstract][Full Text] [Related]
19. DTIC (NSC-45388) studies in the southwest oncology group.
Costanzi JJ
Cancer Treat Rep; 1976 Feb; 60(2):189-92. PubMed ID: 769972
[TBL] [Abstract][Full Text] [Related]
20. An EORTC phase II study of mitoxantrone in solid tumors and lymphomas.
De Jager R; Cappelaere P; Armand JP; Keiling R; Fargeot P; Bastit P; van Glabbeke M; Renard J; Earl H; Rubens R
Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1369-75. PubMed ID: 6542006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
